Swipe om te navigeren naar een ander artikel
The online version of this article (https://doi.org/10.1007/s11136-019-02200-1) contains supplementary material, which is available to authorized users.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To examine the responsiveness of the EQ-5D-3L and EQ-5D-5L among total hip/knee replacement (THR/TKR) patients.
The EQ-5D (3L or 5L) and Western Ontario and McMaster University Osteoarthritis Index (WOMAC) have been routinely administered to all THR/TKR patients before and at 3 months after surgery in Alberta, Canada, since 2010. Patients were included in this analysis if they completed the WOMAC and the same version of EQ-5D at baseline and 3-month follow-up. The WOMAC was used as an anchor to categorize patients into 9 subgroups according to the relative change from baseline, i.e., no change, and 4 categories each for the amount of deterioration or improvement: large (≥ 70%), moderate (50% ≤ change < 70%), small but important (20% ≤ change < 50%), and very mild (0 < change ≤ 20%). The responsiveness of the EQ-5D-3L and EQ-5D-5L for each subgroup was assessed using effect size, standardized response mean, and Guyatt’s Responsiveness Index.
A total of 1594 patients completed the EQ-5D-3L and WOMAC (60% females, mean age 66 years, N = 646 [41%] THR), and 3180 completed the EQ-5D-5L and WOMAC (60% females, mean age 66 years, N = 1352 [43.2%] THR) at baseline and 3-month follow-up. For both THR and TKR patients with “small but important” improvement, the EQ-5D-5L was consistently more responsive than the EQ-5D-3L.
Our study demonstrated that the EQ-5D-5L is more responsive than the EQ-5D-3L in identifying health-related quality of life changes in THR/TKR patients. We recommend using the EQ-5D-5L in longitudinal studies in this patient population.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
American Academy of the Orthopedic Surgeons. Total joint replacement. Accessed August 31, 2018, from https://orthoinfo.aaos.org/en/treatment/total-joint-replacement/.
OECD. (2017). Health at a glance 2017: OECD indicators. Paris: OECD Publishing. CrossRef
Canadian Institute for Health Information. (2018). Hip and knee replacements in Canada, 2016–2017: Canadian joint replacement registry annual report. Ottawa: CIHI.
Núñez, M., Lozano, L., Núñez, E., et al. (2009). Total knee replacement and health-related quality of life: Factors influencing long-term outcomes. Arthritis & Rheumatology, 61(8), 1062–1069. CrossRef
EuroQol Group. EuroQol, About us. Accessed March 1, 2019, from https://euroqol.org/euroqol/.
Costa, M. L., Achten, J., Foguet, P., Parsons, N. R., & Young Adult Hip Arthroplasty Team. (2018). Comparison of hip function and quality of life of total hip arthroplasty and resurfacing arthroplasty in the treatment of young patients with arthritis of the hip joint at 5 years. British Medical Journal Open, 8(3), e018849.
Fernandes, L., Roos, E. M., Overgaard, S., Villadsen, A., & Søgaard, R. (2017). Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial. BMC Musculoskeletal Disorders, 18(1), 5. CrossRefPubMedPubMedCentral
Jenkins, P. J., Clement, N. D., Hamilton, D. F., Gaston, P., Patton, J. T., & Howie, C. R. (2013). Predicting the cost-effectiveness of total hip and knee replacement: A health economic analysis. Bone & Joint Journal, 95(1), 115–121. CrossRef
Insight & Feedback Team, NHS England. (2017). National patient reported outcome measures (PROMs) programme consultation report. London: NHS.
Kärrholm J, Lindahl H, Malchau H, et al. The swedish hip arthroplasty register annual report 2016. Accessed August 31, 2018, from https://registercentrum.blob.core.windows.net/shpr/r/Annual-Report-2016-B1eWEH-mHM.pdf.
Canadian Institute for Health Information. (2015). PROMs forum proceedings. Ottawa: CIHI.
Conner-Spady, B., Marshall, D., Bohm, E., Dunbar, M., & Noseworthy, T. (2018). Comparing the validity and responsiveness of the EQ-5D-5L to the oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement. Quality of Life Research, 27(5), 1311–1322. CrossRefPubMed
EuroQol Group. EQ-5D-3L user guide. Accessed May 11, 2018, from https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-3L_UserGuide_2015.pdf.
EuroQol Group. EQ-5D-5L user guide. Accessed May 11, 2018, from https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdf.
Bellamy, N. (2004). WOMAC osteoarthritis index user guide VII. Brisbane: The University of Queensland.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. New York: Routledge Academic.
Jin, X., Al Sayah, F., Ohinmaa, A., Marshall, D. A., Smith, C., & Johnson, J. A. (2019). The EQ-5D-5L is superior to the -3L version in measuring health-related quality of life in patients awaiting THA or TKA. Clinical Orthopaedics and Related Research. https://doi.org/10.1097/CORR.0000000000000662. CrossRefPubMed
Alberta Bone and Joint Health Institute. Wait times for hip and knee replacement. Accessed January 8, 2019, from https://albertaboneandjoint.com/patients/wait-times/.
Middel, B., & van Sonderen, E. (2002). Statistical significant change versus relevant or important change in (quasi) experimental design: Some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. International Journal of Integrated Care, 2(4), e15. CrossRefPubMedPubMedCentral
- Responsiveness of the EQ-5D-3L and EQ-5D-5L in patients following total hip or knee replacement
Fatima Al Sayah
Deborah A. Marshall
Jeffrey A. Johnson
- Springer International Publishing